Thus, a drug such as metformin that decreases circulating glucose and insulin levels, inhibits mitochondrial complex I, and disrupts the mTOR pathway may be useful in obesity- and mTOR pathway-driven cancers, such as OC. The gene discussed is MTOR; the disease is obesity disorder.